GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...

A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...

Lutein is more than an eye-protecting nutrient. New research reveals its role in brain health and disease prevention. Learn ...